|
Sanchez-Mas J, Lax A, Asensio-Lopez MC, Lencina M, Fernandez-Del Palacio MJ, Soriano-Filiu A, de Boer RA, Pascual-Figal DA. Early Anti-inflammatory and Pro-angiogenic Myocardial Effects of Intravenous Serelaxin Infusion for 72 H in an Experimental Rat Model of Acute Myocardial Infarction. J Cardiovasc Transl Res. 2017 Dec;10(5-6):460-469. doi: 10.1007/s12265-017-9761-1. Epub 2017 Jul 17. PubMed PMID: 28718055.
AÑO: 2017; IF: 2.337
|
28718055
|
Pascual-Figal DA, Bayes-Genis A, Asensio-Lopez MC, Hernandez-Vicente A, Garrido-Bravo I, Pastor-Perez F, Diez J, Ibanez B, Lax A. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure. J Am Coll Cardiol. 2019 Mar 12;73(9):1016-1025. doi: 10.1016/j.jacc.2018.11.054. PubMed PMID: 30846095.
AÑO: 2019; IF: 20.589
|
|
Pascual-Figal DA, Pérez-Martínez MT, Asensio-Lopez MC, Sanchez-Más J, García-García ME, Martinez CM, Lencina M, Jara R, Januzzi JL, Lax A. Pulmonary Production of Soluble ST2 in Heart Failure. Circ Heart Fail. 2018 Dec;11(12):e005488. doi: 10.1161/CIRCHEARTFAILURE.118.005488. PubMed PMID: 30562096.
AÑO: 2018; IF: 6.526
|
|
Revuelta-Lopez E, Lupon J, Lax A, Pascual-Figal DA, Bayes-Genis A. Differences in the Interleukin-1beta/Soluble ST2 Interplay Between Acute and Chronic Heart Failure. J Cardiovasc Transl Res. 2020 Oct;13(5):864-866. doi: 10.1007/s12265-020-09958-7. Epub 2020 Jan 22. PubMed PMID: 31970669.
AÑO: 2020; IF: 4.132
|
|
Iborra-Egea O, Santiago-Vacas E, Yurista SR, Lupon J, Packer M, Heymans S, Zannad F, Butler J, Pascual-Figal D, Lax A, Nunez J, de Boer RA, Bayes-Genis A. Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes. JACC Basic Transl Sci. 2019 Oct 23;4(7):831-840. doi: 10.1016/j.jacbts.2019.07.010. eCollection 2019 Nov. PubMed PMID: 31998851; PubMed Central PMCID: PMC6978551.
AÑO: 2019; IF: 8.648
|